ME00246B - Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa - Google Patents
Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfaInfo
- Publication number
- ME00246B ME00246B MEP-2008-473A MEP47308A ME00246B ME 00246 B ME00246 B ME 00246B ME P47308 A MEP47308 A ME P47308A ME 00246 B ME00246 B ME 00246B
- Authority
- ME
- Montenegro
- Prior art keywords
- anhydrate
- hfa
- suspension formulation
- formulation
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10214264A DE10214264A1 (de) | 2002-03-28 | 2002-03-28 | HFA-Suspensionsformulierungen eines Anhydrats |
| PCT/EP2003/002899 WO2003082244A2 (fr) | 2002-03-28 | 2003-03-20 | Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MEP47308A MEP47308A (en) | 2011-02-10 |
| ME00246B true ME00246B (fr) | 2011-05-10 |
Family
ID=28050990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-473A ME00246B (fr) | 2002-03-28 | 2003-03-20 | Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1492498A2 (fr) |
| JP (1) | JP5147158B2 (fr) |
| KR (1) | KR101005717B1 (fr) |
| CN (1) | CN1642525A (fr) |
| AU (1) | AU2003221509B2 (fr) |
| BR (1) | BR0308709A (fr) |
| CA (1) | CA2479638C (fr) |
| DE (1) | DE10214264A1 (fr) |
| EA (1) | EA008610B1 (fr) |
| EC (1) | ECSP045322A (fr) |
| HR (1) | HRP20040890A2 (fr) |
| IL (1) | IL163696A0 (fr) |
| ME (1) | ME00246B (fr) |
| MX (1) | MXPA04009338A (fr) |
| NO (1) | NO20044004L (fr) |
| NZ (1) | NZ536030A (fr) |
| PL (1) | PL371295A1 (fr) |
| RS (1) | RS52481B (fr) |
| UA (1) | UA79776C2 (fr) |
| WO (1) | WO2003082244A2 (fr) |
| ZA (1) | ZA200405637B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1881980E (pt) * | 2005-05-02 | 2012-12-06 | Boehringer Ingelheim Int | Novas formas cristalinas de brometo de tiotrópio |
| CA2606552A1 (fr) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Formes cristallines de bromure de tiotropium |
| AU2015201037C1 (en) * | 2009-05-29 | 2017-07-27 | Pearl Therapeutics, Inc. | Respiratory delivery of active agents |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| TWI792140B (zh) * | 2009-05-29 | 2023-02-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統 |
| TR201902687T4 (tr) | 2013-03-15 | 2019-03-21 | Pearl Therapeutics Inc | İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler. |
| EP3515439B1 (fr) * | 2016-09-19 | 2021-12-15 | Mexichem Fluor S.A. de C.V. | Composition pharmaceutique comprenant du bromure de tiotropium |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| DK1102579T3 (da) * | 1998-08-04 | 2003-07-14 | Jago Res Ag | Medicinske aerosolformuleringer |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| GB0009605D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
| GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
| GB0009592D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
| DE10111058A1 (de) * | 2001-03-08 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten |
| DE10113366A1 (de) * | 2001-03-20 | 2002-09-26 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten |
| AU2002214030A1 (en) * | 2000-10-31 | 2002-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses |
-
2002
- 2002-03-28 DE DE10214264A patent/DE10214264A1/de not_active Withdrawn
-
2003
- 2003-03-20 RS YU86004A patent/RS52481B/en unknown
- 2003-03-20 EA EA200401159A patent/EA008610B1/ru unknown
- 2003-03-20 PL PL03371295A patent/PL371295A1/xx not_active Application Discontinuation
- 2003-03-20 UA UA20041008758A patent/UA79776C2/uk unknown
- 2003-03-20 BR BR0308709-3A patent/BR0308709A/pt active Pending
- 2003-03-20 ME MEP-2008-473A patent/ME00246B/fr unknown
- 2003-03-20 NZ NZ536030A patent/NZ536030A/en not_active IP Right Cessation
- 2003-03-20 EP EP03717219A patent/EP1492498A2/fr not_active Withdrawn
- 2003-03-20 IL IL16369603A patent/IL163696A0/xx unknown
- 2003-03-20 CA CA2479638A patent/CA2479638C/fr not_active Expired - Fee Related
- 2003-03-20 WO PCT/EP2003/002899 patent/WO2003082244A2/fr active Application Filing
- 2003-03-20 KR KR1020047015174A patent/KR101005717B1/ko active IP Right Grant
- 2003-03-20 MX MXPA04009338A patent/MXPA04009338A/es active IP Right Grant
- 2003-03-20 AU AU2003221509A patent/AU2003221509B2/en not_active Expired
- 2003-03-20 CN CNA038072475A patent/CN1642525A/zh active Pending
- 2003-03-20 JP JP2003579782A patent/JP5147158B2/ja not_active Expired - Lifetime
-
2004
- 2004-07-15 ZA ZA2004/05637A patent/ZA200405637B/en unknown
- 2004-09-23 NO NO20044004A patent/NO20044004L/no not_active Application Discontinuation
- 2004-09-27 HR HR20040890A patent/HRP20040890A2/hr not_active Application Discontinuation
- 2004-09-28 EC EC2004005322A patent/ECSP045322A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20044004L (no) | 2004-10-05 |
| HRP20040890A2 (en) | 2005-06-30 |
| NZ536030A (en) | 2006-07-28 |
| CA2479638C (fr) | 2011-01-04 |
| KR20040098022A (ko) | 2004-11-18 |
| EP1492498A2 (fr) | 2005-01-05 |
| PL371295A1 (en) | 2005-06-13 |
| JP5147158B2 (ja) | 2013-02-20 |
| ECSP045322A (es) | 2005-01-28 |
| CN1642525A (zh) | 2005-07-20 |
| CA2479638A1 (fr) | 2003-10-09 |
| EA008610B1 (ru) | 2007-06-29 |
| RS52481B (en) | 2013-02-28 |
| KR101005717B1 (ko) | 2011-01-05 |
| MEP47308A (en) | 2011-02-10 |
| MXPA04009338A (es) | 2005-01-25 |
| WO2003082244A3 (fr) | 2004-02-05 |
| YU86004A (sh) | 2006-08-17 |
| UA79776C2 (en) | 2007-07-25 |
| AU2003221509B2 (en) | 2008-01-24 |
| EA200401159A1 (ru) | 2005-04-28 |
| DE10214264A1 (de) | 2003-10-16 |
| WO2003082244A2 (fr) | 2003-10-09 |
| JP2005527550A (ja) | 2005-09-15 |
| BR0308709A (pt) | 2005-01-04 |
| ZA200405637B (en) | 2005-07-27 |
| AU2003221509A1 (en) | 2003-10-13 |
| IL163696A0 (en) | 2005-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401142A1 (ru) | Микронизированный кристаллический тиотропийбромид | |
| MEP62008A (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of a drug | |
| ME00243B (me) | Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka | |
| CY1105210T1 (el) | Μεθοδος για την παρασκευη προδρομου ενωσης του αντιχολινενepγου tiotropiumbromid | |
| CY1105543T1 (el) | Σκευασματα εναιωρηματων με hfa που περιεχουν αντιχολινεργικο | |
| DK1087960T3 (da) | Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling | |
| DK1401837T3 (da) | Purinderivater som A2B-adenosinreceptorantagonister | |
| ES2162614T1 (es) | Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas. | |
| GT199900055A (es) | Nuevas dihidropirimidinas2 heterocìclicamente sustituidas. | |
| WO1999066063A3 (fr) | Conjugues de folates nucleosidiques et non nucleosidiques | |
| RS51436B (en) | DERIVATIVES TRIAZOLIL TROPANA KAO MODULATORS CCR5 | |
| HUP0302284A2 (hu) | Egy triazolo[4,5-d]pirimidin-vegyület új kristályos és amorf formái | |
| HRP20020428B1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| GB2380675A (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
| AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
| ME00246B (fr) | Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa | |
| AR039670A1 (es) | Derivados de 1,2,3,4,7,8-hexahidro-6h-[1,4] diazepino [6,7,1j] quinolina como agentes antipsicoticos y antiobesidad | |
| AR086573A2 (es) | Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica | |
| WO2003082855A1 (fr) | Agent anti-inflammatoire | |
| EP0716083A4 (fr) | Derives de la benzazepine, composition pharmaceutique le contenant, et ses intermediaires | |
| EP1757285A4 (fr) | Agent préventif et/ou thérapeutique pour la sinusite chronique | |
| AU2002328824A1 (en) | Isoflavone concentrate and method for production thereof | |
| ECSP034921A (es) | Anticolinérgico cristalino, metodo para su producción, y uso del mismo en la producción de una droga |